Status:

COMPLETED

Effect of Prebiotics Versus Low FODMAPs Diet on Intestinal Microbiota and Symptoms

Lead Sponsor:

Hospital Universitari Vall d'Hebron Research Institute

Conditions:

Functional Gastrointestinal Disorders

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

It has been shown that patients complaining of gas-related symptoms significantly improve on a diet low in fermentable residues. However, other studies suggest that some non-absorbable, fermentable me...

Eligibility Criteria

Inclusion

  • Functional digestive disorder with flatulence
  • Women and men between the ages of 18 and 80 years (bounds included at the inclusion visit).
  • Normal body weight or with overweight (body mass index between 18.0 and 30.0 kg/m2 (bounds included)).
  • Women of childbearing potential should be using or complying with one of the medically approved methods of contraception such as, but not exclusively, one of the following:
  • Birth control pill
  • Intra-uterine device (IUD)
  • Double barrier methods (such as condoms and spermicide)
  • Abstinence
  • Willing to follow strict dietary instructions for the duration of the study
  • Able to communicate well with the investigator and to comply with the requirements for the study.

Exclusion

  • Significant illness other than functional bowel disorders
  • Disease/disorders which can interfere with the collection of the gas (hemorrhoids,..etc)
  • Antecedents of digestive surgery, excluding appendicectomy
  • Intake of antibiotics in the month (within 30 days) preceding the inclusion visit.
  • Current use of any medications with potential central nervous system effects as judged by the investigator (including but not limited to antidepressants, anxiolytics, opiate pain medications)
  • Taking drugs that might modify gastrointestinal function
  • Change of dietary habits within the preceding 4 weeks (for instance start of a diet high in fiber) or planned change (For example to start a diet) during the period of the study

Key Trial Info

Start Date :

August 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2015

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT02210572

Start Date

August 1 2014

End Date

July 1 2015

Last Update

November 30 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vall d'Hebron Research Institute

Barcelona, Barcelona, Spain, 08035